Does ENZALUTAMIDE Cause Muscle atrophy? 127 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 127 reports of Muscle atrophy have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.3% of all adverse event reports for ENZALUTAMIDE.
127
Reports of Muscle atrophy with ENZALUTAMIDE
0.3%
of all ENZALUTAMIDE reports
2
Deaths
16
Hospitalizations
How Dangerous Is Muscle atrophy From ENZALUTAMIDE?
Of the 127 reports, 2 (1.6%) resulted in death, 16 (12.6%) required hospitalization.
Is Muscle atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 127 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Muscle atrophy?
FINASTERIDE (447)
CIPROFLOXACIN (381)
ATORVASTATIN (340)
ADALIMUMAB (316)
RELUGOLIX (260)
LEUPROLIDE (254)
SIMVASTATIN (247)
LEVOFLOXACIN (185)
ROSUVASTATIN (177)
PREDNISONE (171)
Which ENZALUTAMIDE Alternatives Have Lower Muscle atrophy Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE